Expression of integrin in hepatic fibrosis and intervention of resveratrol

Abstract

The aim of this study was to explore the expression of integrin-β1 in different stages of hepatic fibrosis and intervention of resveratrol as well as the way by which integrin-β1 promoted hepatic fibrosis. Hepatic fibrosis models of male Sprague Dawley (SD) rats were created and intragastric administration of resveratrol was given in low (40 mg/kg), middle (120 mg/kg) and high (200 mg/kg) dose groups. The expression of integrin-β1, tumor growth factor-β (TGF-β) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in different stages of hepatic fibrosis was detected by using RT-PCR. The expression of hexadecenoic acid (HA) and precollagen III (pc III) was assayed by radioimmunoassay. The expression of integrin-β1, TGF-β and TIMP-1 was determined in each group. Liver function and pathological sections of each group in different stages of hepatic fibrosis was tested to judge the therapeutic efficacy of resveratrol at different doses. The expression of integrin-β1 in normal control group was low and steady and was not increased as the development of hepatic fibrosis, but it is increased in other groups. The expression levels of integrin-β1 in the model control group (0.878±0.03, P<0.01) and low dose group (0.855±0.04, P<0.01) were higher than other groups, but there was no difference between model control group and low dose group (P>0.05). The expression levels of integrin-β1 and TGF-β in middle dose group and high dose group were higher than other groups (P<0.01). The expression levels of integrin-β1 and TGF-β in model control group and low dose group were lower than the normal control group (P<0.01). The expression levels of TIMP-1 in the model control and low dose groups were higher than the other groups (P<0.01). The expression levels of TIMP-1 in the middle dose group and the high dose group were lower than the normal control group (P<0.01). The expression of integrin-β1 existed in all stages of hepatic fibrosis of SD rats, and it was increased as the development of hepatic fibrosis. The expression of TGF-β and TIMP-1 was consistent with that of integrin-β1 in different stages of hepatic fibrosis. Resveratrol could improve the degree of hepatic fibrosis of SD rats and decrease the expression of integrin-β1 markedly at a dose of 120 mg/kg.

Key words： liver fibrosis; integrin-β1; resveratrol; tumor growth factor-β; tissue inhibitor of metalloproteinase-1

Acknowledgements

The study was supported by the Natural Science Foundation of Shanghai (No. 06ZR14090).

References

1 Scoazec J Y. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis. J Hepatol, 1995, 22(2 Suppl): 20-27

2 Levine D, Rockey D C, Milner T A, Johannes M. Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis. Am J Pathol, 2000, 156 (6): 1927-1935

3 Zhou X, Zhang Y, Zhang J, Zhu H, Zhou X, Du W, Zhang X, Chen Q. Expression of fibronectin receptor, integrin alpha 5 beta 1 of hepatic stellate cells in rat liver fibrosis. Chin Med J (Engl), 2000, 113(3): 272-276

4 Nejjari M, Couvelard A, Mosnier J F. Integrin up-regulation in chronic liver disease: relationship with inflammation and fibrosis in chronic hepatitis C. J Pathol, 2001, 195(4): 473-481

5 Arloni V, Romanelli R G, Pinzani M. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology, 2003, 110(4): 1127-1136

6 Yamauchi M, Mizuhara Y, Maezawa Y. Serum levels of integrins in chronic liver diseases. Pathol Res Pract, 2004, 190(9-10): 984-992

7 Zhou X, Zhang Y, Zhang J. Expression of fibronectin receptor, integrin alpha 5 beta 1 of hepatic stellate cells in rat liver fibrosis. Chin Med J (Engl), 2000, 113(3): 272-276

8 Yang C, Zeisberg M, Mosterman B. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology, 2003, 124(1): 147-159

9 Xu X, Li Y M, Ji H, Hou C Z. Changes of ECM and CAM gene expression profile in the cirrhotic liver after HCV infection: analysis by cDNA expression array. World J Gastroenterol, 2005, 11(14): 2184-2187

10 Shakado S, Sakisaka S, Noguchi K. Effects of extracellular matrices on tube formation of cultured rat hepatic sinusoidal endothelial cells. Hepatology, 2005, 22(3): 969-973

11 Humphries M J. Integrin structure. Biochem Soc Trans, 2000, 28 (4): 311-339

12 Chigaev A, Zwartz G, Graves S W. Alpha4beta1 integrin affinity changes govern cell adhesion. J Biol Chem, 2003, 278(40): 38174-38182

13 Marra F, Pastacaldi S, Romanelli R G. Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett, 2001, 414(2): 221-225

14 Fujii K. Ligand activation of overexpressed epidermal growth factor receptor results in loss of epithelial phenotype and impaired RGD-sensitive integrin function in HSC-1 cells. J Invest Dermatol, 2003, 107(2): 195-202

15 Levine D, Rockey D C, Milner T A. Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis. Am J Pathol, 2000, 156(6): 1927-1935

16 Kato R, Kamiya S, Ueki M. The fibronectin-derived antiadhesive peptides suppress the myofibroblastic conversion of rat hepatic stellate cells. Exp Cell Res, 2001, 265(1): 54-63

17 Carloni V, Romanelli R G, Pinzani M. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology, 2001, 112(2): 522-531

18 Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis, 2001, 21(3): 397-416

19 Moore C, Shen X D, Fondevila C. Fibronectin-alpha4beta1 integrin interactions modulate p42/44 MAPK phosphorylation in steatotic liver cold ischemia-reperfusion injury. Transplant Proc, 2005, 37(1): 432-434

20 Iwamoto H, Sakai H, Nawata H. Inhibition of integrin signaling with Arg-Gly-Asp motifs in rat hepatic stellate cells. J Hepatol, 2000, 29 (5): 752-759

21 Milliano M T, Luxon BA. Initial signaling of the fibronectin receptor (alpha5beta1 integrin) in hepatic stellate cells is independent of tyrosine phosphorylation. J Hepatol, 2003, 39(1): 32-37

22 Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver, 2000, 18(1): 2-13

23 Danen E H, Lafrenie R M, Miyamoto S. Integrin signaling: cytoskeletal complexes, MAP kinase activation, and regulation of gene expression. Cell Adhes Commun, 2003, 6(2-3): 217-224

24 Yoshimoto N, Togo S, Kubota T. Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats. J Endotoxin Res, 2005, 11(1): 33-39

25 Wang H, Mengsteab S, Tag C G. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol, 2005, 11(13): 929-936

26 Tian J W, Yang J X, Fu F H, Jiang W L, Wang Z H, Wang C Y. Protection effect of polydatin to primary cultured rat hepatic cell injury induced by ·OH. Zhongguo Yaolixue Tongbao, 2003, 19(11): 543-545 (in Chinese)

27 Zhong F, Luo S J, Tang S M. New progression of resveratrol inhibit cell proliferation. Zhongcaoyao, 2003, 34(5): 2-4 (in Chinese)

28 Jiang W Q, Sheng J F. Pharmaco-activity and mechanism of action of resveratrol. Progress in Pharmaceutical Sciences, 2003, 27(3): 159-162

29 Lu Q J, Qiong J, Liqing Weng .Effect of resveratrol on rat chronic hepatic fibrosis, Zhongguo Xinyao Zazhi, 2005, 14(7): 855-858 (in Chinese)

30 Hong Z Y, Gao Y, Zhan X H. Morphology research on giant knotweed rhizome in protection of liver ischemic damage of rat. Shijie Huaren Xiaohua Zazhi, 2000, 8(2): 162-164 (in Chinese)